H.R. 4384 - Patient Safety and Drug Labeling Improvement Act
- Sponsor:
- Chris Van Hollen
- Summary:
- To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. (by CRS)
- Status:
- The bill has been introduced.
Patient Safety and Drug Labeling Improvement Act
H.R. 4384 — 112th Congress (2011–2012)
- Summary
- To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so. (by CRS)
- Learn More
- At OpenCongress
- Title
- To permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.
- Other Titles
- Patient Safety and Drug Labeling Improvement Act
- Sponsor
- Chris Van Hollen
- Co-Sponsors
- Subjects
- Health
- Consumer affairs
- Drug safety, medical device, and laboratory regulation
- Health information and medical records
- Prescription drugs
- Related Bills
- Major Actions
Introduced 4/18/2012 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 4/18/2012 4/18/2012 Referred to the House Committee on Energy and Commerce. 4/20/2012 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
supported this bill
opposed this bill
Contributions data source: OpenSecrets.org
